Abstract

The theory of cancer stem cells (CSCs) proposes that the different cells within a tumor, as well as metastasis deriving from it, are originated from a single subpopulation of cells with self-renewal and differentiation capacities. These cancer stem cells are supposed to be critical for tumor expansion and metastasis, tumor relapse and resistance to conventional therapies, such as chemo- and radiotherapy. The acquisition of these abilities has been attributed to the activation of alternative pathways, for instance, WNT, NOTCH, SHH, PI3K, Hippo, or NF-κB pathways, that regulate detoxification mechanisms; increase the metabolic rate; induce resistance to apoptotic, autophagic, and senescence pathways; promote the overexpression of drug transporter proteins; and activate specific stem cell transcription factors. The elimination of CSCs is an important goal in cancer therapeutic approaches because it could decrease relapses and metastatic dissemination, which are main causes of mortality in oncology patients. In this work, we discuss the role of these signaling pathways in CSCs along with their therapeutic potential.

Highlights

  • The understanding on the tumorigenesis process has been explained during decades according to the clonal evolution model

  • The tumors contain a subset of different tumor cells, called cancer stem cells that are crucial for tumor initiation, progression, and recurrence [3, 4]

  • Some articles suggest that the role of Wnt in the regulation of cancer stem cells (CSCs) differs depending on the types of cancer, such as blood, intestine, lung, mammary, gland, nervous system, skin, and urinary tract

Read more

Summary

Therapeutic Targeting of Signaling Pathways Related to Cancer Stemness

Asunción Espinosa-Sánchez , 1,2† Elisa Suárez-Martínez , 1,2† Laura Sánchez-Díaz 1,2† and Amancio Carnero 1,2*. Specialty section: This article was submitted to Cancer Metabolism, a section of the journal

Frontiers in Oncology
INTRODUCTION
Therapeutic Targeting of Stemness
WNT PATHWAY
Cancer Stem Cells
Therapeutic Targets and Drugs
Solid and hematological malignancies
NOTCH PATHWAY
SONIC HEDGEHOG PATHWAY
HIPPO PATHWAY
TLR PATHWAY
Future Treatment Opportunities Targeting the TLR
OXIDATIVE STRESS AND CSCs
Findings
CONCLUSIONS

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.